Professor Maralyn Druce from Queen Mary University of London has been announced as a new National Teaching Fellow by Advance HE today.
Closed Loop Medicine (CLM), the Cambridge based therapeutics company that helps doctors and healthcare providers to deliver personalised treatment regimens, has raised £1.3 million in research grant funding from the InnovateUK Innovation Accelerator, Longwall Ventures and IQ Capital.
We are pleased to announce that Dr Fu Liang Ng, Clinical Senior Lecturer in Clinical Pharmacology at the William Harvey Research Institute, was voted Teacher of the Year by the MBBS students for 2019. The award is in recognition of the dedication and hard that goes into the Medicine programme at the School of Medicine and Dentistry.
2019 WHRI Annual Review Summary
27 June 2019
The William Harvey Annual Review took place on the 12th of June 2019 at the Derek Willoughby Lecture Theatre, Charterhouse Square.
A new joint study involving researchers at Queen Mary University of London has identified background subclinical changes on the electrocardiodiagram as risk factors in cardiovascular mortality.
The Centre for Experimental Medicine and Rheumatology (EMR) at the William Harvey Research Institute is committed to engaging with the public and has participated in the Barts and Queen Mary Science Festival for a number of years, offering children the opportunity to try gloves that simulate the effect of arthritis and to ‘see’ inside their joints using ultrasound, so when QMUL Arts and Culture asked for proposals for the 2019 Tate Exchange EMR decided to build on this and submit a project.
Genetic Risk Score for Coronary Disease Identifies Predispositions to Cardiovascular and Non-Cardiovascular Diseases
11 June 2019
A new study by researchers at Queen Mary University of London has shown how genetic predisposition to coronary heart disease (including heart attacks) is genetically correlated to other diseases.
Leading genomics expert awarded knighthood in the Queen's birthday honours
7 June 2019
Professor Mark Caulfield, the interim Chief Executive at Genomics England and Professor of Clinical Pharmacology at Queen Mary University of London, has been awarded a knighthood in the Queen’s Birthday Honours List.
Drinking coffee might keep us up at night, but new research has given us a reason to sleep easy knowing that the popular drink isn’t as bad for our arteries as some previous studies would suggest.
Follow us on LinkedIn
30 May 2019
We are pleased to announce that we are now officially in LinkedIn.
DNA discovery could have implications for mitochondrial donation treatment
23 May 2019
Mitochondria, the ‘batteries’ that produce our energy, interact with the cell’s nucleus in subtle ways previously unseen in humans, according to research involving academics from Queen Mary University of London.
A clinical trial, coordinated by researchers from Queen Mary University of London, is currently recruiting patients in London to see whether a new cholesterol-lowering drug could save lives in people who are intolerant to statins.
Researchers from Queen Mary University of London studied the effectiveness of one of the largest ever national quality improvement programmes in the National Health Service (NHS) and found no improvement in patient survival.
Results from a study led by researchers from Queen Mary University of London has found that an association between shorter stature and higher risk of heart disease is mainly attributed to our lungs.
Researchers from Queen Mary University of London are about to start work on a new EU-funded project to discover novel therapeutic targets for osteoarthritis and rheumatoid arthritis.
A publication by researchers from the Centre for Microvascular Research at the William Harvey Research Institute has received the highly prestigious Servier Award in Microcirculation.
The British Heart Foundation (BHF) has this week announced £34million of new funding across 12 universities, in a move that strengthens world-class, UK-led heart and circulatory disease research.
Working long hours linked to depression in women
26 February 2019
Women who work more than 55 hours a week are at a higher risk of depression compared to men, according to a UCL-led study with Queen Mary University of London.
The winners of Queen Mary’s new scheme of annual Education Excellence Awards and President and Principal’s Prizes were announced at a ceremony on 20 February 2019.
Professor Federica Marelli-Berg from Queen Mary University of London has been named by the British Heart Foundation (BHF) as one of the top 10 inspirational women in science.
UK Health Secretary Matt Hancock has today announced that a project involving Queen Mary University of London researchers has reached its goal of sequencing 100,000 whole genomes from NHS patients.
WHRI researchers in top 1 per cent worldwide
27 November 2018
Three researchers from the William Harvey Research Institute have been placed in the top 1 per cent in the world, in this year's highly cited Researchers list.
Researcher in Focus
22 November 2018
Dr Gloria Lliso-Ribera, Clinical Research Fellow at the Centre for Experimental Medicine and Rheumatology talks about life as a WHRI researcher.
Professor Chris Thiemermann honoured for his contributions to science
8 November 2018
In October 2018, Chris Thiemermann, Professor of Pharmacology and Centre Lead for Translational Medicine & Therapeutics at the William Harvey Research Institute, received the prestigious Albert Nelson Marquis Lifetime Achievement Award.
Professor Márta Korbonits delivers inaugural Lady Estelle Wolfson lecture at RCP
29 October 2018
Professor Márta Korbonits gave the Lady Estelle Wolfson lecture in translational medicine at the Royal College of Physicians on the 24th October 2018 during the Acute and General Medicine Conference.
Genetic tool to predict adult heart disease risk in childhood
10 October 2018
People at high risk of a heart attack in adulthood could be identified much earlier in life with a one-off DNA test, according to new research published in the Journal of the American College of Cardiology.
Landmark TB research announced at the UN General Assembly
27 September 2018
A landmark international research project, involving researchers from Queen Mary University of London, has shown that we can now use our knowledge of the tuberculosis (TB) genetic code to predict which drugs are best for treating a patient’s infection.
Researchers awarded for lifetime achievements in blood pressure research
24 September 2018
Two academics from Queen Mary University of London have received prestigious awards from the International Society of Hypertension (ISH) in recognition of their achievements in blood pressure research.
Study of one million people leads to world's biggest advance in blood pressure genetics
17 September 2018
Over 500 new gene regions that influence people’s blood pressure have been discovered in the largest global genetic study of blood pressure to date, led by Queen Mary University of London and Imperial College London.
Death rates from heart disease and stroke could be significantly lowered by prescribing statins alongside blood pressure-lowering drugs, according to the results from a clinical trial led by Queen Mary University of London and Imperial College London.
Graduation joy for WHRI Pharmacology students
30 July 2018
On Thursday 26 July 2018, the first ever cohort of students from our BSc Pharmacology and Innovative Therapeutics programme were honoured at the QMUL Graduation Ceremony at the Mile End Campus.
Professor Márta Korbonits, Professor of Endocrinology at Barts and the London School of Medicine and Dentistry, Queen Mary University of London, Scientific Programme Chair of the European Society of Endocrinology, and representative of BioMed Alliance, will be discussing the effects of Brexit on the European Reference Networks (ERNs), in Westminster, Monday 9 July.
Q&A with Dr Li Chan
8 June 2018
Research paper: MRAP deficiency impairs adrenal progenitor cell differentiation and gland zonation.
New lab technology could reveal treatments for muscle-wasting disease
6 June 2018
Researchers from Queen Mary University of London have developed new cell-based technologies which could improve understanding of the muscle-wasting disease Duchenne muscular dystrophy (DMD) and test potential drugs for the disease.
Surgery involving ultrasound energy found to treat high blood pressure
23 May 2018
An operation that targets the nerves connected to the kidney has been found to significantly reduce blood pressure in patients with hypertension, according to the results of a clinical trial led in the UK by Queen Mary University of London and Barts Health NHS Trust, and supported by the National Institute for Health Research (NIHR).
Lunch & Learn: Cutting Edge Studies in Autoimmune disease
18 May 2018
Crown Bioscience and Dr. Ahuva Nissim, Queen Mary University of London, are delighted to invite you to attend our Lunch and Learn Seminar on Cutting Edge Studies in Autoimmune Disease on 1 June 2018.
QMUL and UCL joint study identifies genes linked to impaired capacity to modulate heart rate during and after exercise
17 May 2018
A new study by researchers at Queen Mary University of London (QMUL) and University College London (UCL) has discovered 30 new gene locations that determine how the heart responds to and recovers from exercise.
Queen Mary University of London has appointed four research fellows to its new Rutherford Academy of Population Genomics and Health Data Science, funded by the Medical Research Council and UK Research and Innovation's Rutherford Fund.
Professor Panos Deloukas elected as Fellow of The Academy of Medical Sciences
10 May 2018
Professor of Cardiovascular Genomics at the William Harvey Research Institute has been recognised for contributions to genomic medicine.
Professor Gustav Born: 29th July 1921 - 16 April 2018
25 April 2018
A message on behalf of Professor Steve Thornton, Vice Principal (Health).
Pint of Science Festival, 14-16 May 2018
13 April 2018
Pint of Science QMUL brings scientists out of the lab and in to your local pub. Tickets are now available for the world's largest festival of public science talks, which will see >25 QMUL scientists take to the stage in pubs across London.
Hormone imbalance causes treatment-resistsance hypertension
12 April 2018
British researchers have discovered a hormone imbalance that explains why it is very difficult to control blood pressure in around 10 per cent of hypertension patients.
New project to transform treatment for children with arthritis
28 March 2018
Researchers from Queen Mary University of London will join a UK-wide effort to drive the development of new treatments for children and young people with juvenile idiopathic arthritis (JIA) and its associated eye-inflammation condition, uveitis.
Weak hand grip could be sign of a failing heart
14 March 2018
Hand grip strength could be used as a simple measure of heart health, according to new research led by scientists at Queen Mary University of London.
Menopausal hormone therapy linked to having a healthier heart
09 March 2018
Women who use menopausal hormone therapy appear to have a heart structure and function that is linked to a lower risk of heart failure, according to a study led by Queen Mary University of London.
New insights into why patients have a higher risk of heart attack in the morning
08 March 2018
Cardiovascular disease patients have lower levels of an important family of protective molecules in their blood in the morning, which could be increasing their risk of blood clots and heart attacks at those times, according to early research led by Queen Mary University of London.
Aspirin helps treat tuberculous meningitis
07 March 2018
The painkiller aspirin appears to reduce the risk of stroke and death in patients with the most deadly form of tuberculosis, according to a study by Queen Mary University of London, Oxford University Clinical Research Unit (Vietnam), Western General Hospital and University of Oxford.
Isolated white blood cell packages from patients with rheumatoid arthritis shown to be protective against inflammation
01 March 2018
A new study by researchers from Queen Mary University of London finds that small packages released by white blood cells during inflammation can be used to prevent the activation of other white blood cells.
Dr Suchita Nadkarni's 'The Placenta Rainbow' featured in National Geographic
27 February 2018
Photo by William Harvey Research Institute and British Heart Foundation (BHF) Research Fellow shows differences in mouse placental development that can result from manipulation of the mother’s immune system.
“Beetroot pill” may help save patients from kidney failure after heart x-ray
22 February 2018
Beetroot may reduce the risk of kidney failure in patients having a heart x-ray, according to research led by Queen Mary University of London.
£54 million award to transform health through data science
7 February 2018
Queen Mary University of London has partnered with four other London universities - UCL, Imperial College London, King's College London and The London School of Hygiene & Tropical Medicine - in a new initiative to transform health through data science.
100,000 Genomes Project to sequence its 500th genome later this month
06 February 2018
Professor Mark Caulfield spoke to Observer Science Editor Robin McKie about the pioneering work of the 100,000 Genomes Project as it approaches its halfway point.
Multinational companies continue to produce unregulated antibiotics in India
06 February 2018
Millions of unapproved antibiotics are being sold in India, according to a new joint study led by Dr Patricia McGettigan from the William Harvey Research Institute.
The first step in generating an artificial adrenal gland
31 January 2018
In a new study, published in Cell Reports, researchers from Queen Mary University of London used cells derived from urine to take the first step in generating an artificial adrenal gland, which could help develop future treatments for adrenal gland disorders.
Diabetes gene found that causes low and high blood sugar levels in the same family
16 January 2018
A study of families with rare blood sugar conditions has revealed a new gene thought to be critical in the regulation of insulin, the key hormone in diabetes.